PLOD1 and chronic obstructive pulmonary disease: Corticosteroid treatment is commonly used for short-term periods during COPD exacerbations [1] and may have an indirect effect on ED incidence: glucocorticoids alter hypothalamus–pituitary–gonadal axis function, inhibiting GnRH synthesis and consequently LH release [91,92].